Related Experiment Video

Updated: Aug 16, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Viral oncology

George Winter

    Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
    |September 2, 2005
    PubMed

    Insights

    The first cancer vaccine targeted hepatitis B virus in 1984. Subsequent research led to a human papillomavirus vaccine in 1999, advancing cancer prevention strategies.

    Area of Science:

    • Oncology
    • Virology
    • Immunology

    Background:

    • The development of vaccines has been crucial in preventing infectious diseases.
    • Cancer prevention through vaccination represents a significant advancement in public health.

    Purpose of the Study:

    • To highlight key milestones in the development of cancer-preventing vaccines.
    • To provide historical context for the ongoing research in cancer vaccines.

    Main Methods:

    • Historical review of vaccine development timelines.
    • Identification of major human cancer-related virus vaccines.

    Main Results:

    • The first vaccine targeting a major human cancer was against the hepatitis B virus, introduced in 1984.
    • A vaccine for human papillomavirus (HPV), another major cancer-causing virus, was developed in 1999.

    Conclusions:

    • Vaccine development has successfully targeted major human cancers.
    • Continued research in vaccinology holds promise for further cancer prevention strategies.

    More Related Videos

    Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

    Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

    Published on: April 3, 2018

    Related Concept Videos

    Rous Sarcoma Virus (RSV) and Cancer01:03

    Rous Sarcoma Virus (RSV) and Cancer

    Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
    RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
    Rous Sarcoma Virus (RSV) and Cancer01:03

    Rous Sarcoma Virus (RSV) and Cancer

    Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
    RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
    Mechanisms of Retrovirus-induced Cancers01:51

    Mechanisms of Retrovirus-induced Cancers

    Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
    Mechanisms of Retrovirus-induced Cancers01:51

    Mechanisms of Retrovirus-induced Cancers

    Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...